Diagnosis

Psoriasis

Chronic, non-infectious, inflammatory skin disorder, characterized by well-defined pink scaling plaques.

Etiology

Cause [syb]

Pathogenesis [syb]

  1. Autoimmune disease mediated by T lymphocytes

  2. Dermal infiltration of activated T cells --> stimulate the proliferation of keratinocytes

  3. Dysregulation in keratinocyte turnover:

    • Epidermal hyperplasia

    • Parakeratosis

    • Cells fail to secrete lipids --> formation of thick plaques

  4. These factors induce each other, leading to a vicious cycle of keratinocyte proliferation and inflammatory reaction

  5. Classification:

    • Type 1 psoriasis: Positive family history, before age 40, associated with HLA-Cw6

    • Type 2 psoriasis: No family history, after age 40, not associated with HLA-Cw6

  6. Typical clinical manifestation:

    • Lesions: Well-defined erythematous plaques covered with silvery scales

    • Localization: scalp, extensors of knees/elbows, and lumbosacral region

Types of psoriasis [nov]

Complications [syb]

Epidemiology

Incidence per 100.000 [1be][noe][24u][py9][rfm][aie][n1y][adg][8b6][a8u]

Epidemiology chart for Incidence

Prevalence per 100.000 [1be][noe][24u][py9][rfm][aie][n1y][adg][8b6][a8u]

Epidemiology chart for Prevalence

Symptoms & findings

Symptoms

Arthralgia, Arthritis, Blepharitis, Conjunctivitis, Fever, Koebner phenomenon, Malaise, Nail pitting, Onycholysis, Pruritus, Subungal hyperkeratosis, Xeroderma

Clinical findings

Elevated Uric Acid

Anamneses

None listed.

Localized findings

Rash
Radiates
CaputThoraxAbdomenGenitalArmBackLower body
Distribution
ExtensorIntertriginousMultipleSymmetric
Lesion type
ExcoriationPlaquePustuleScale
Lesion configuration
GuttateKoebner phenomenon
Lesion surface
Desquamation
Color
Red
Associated symptom
Itch

Approach

Treatment

  1. Nondrug therapy:

    • Phototherapy: Combines psoralen with exposure to ultraviolet light

    • Stress reduction

    • Sunshine, sea bathing, moisturizers, oatmeal baths

    • Punctal occlusion (and ocular lubricants): For keratoconjunctivitis sicca

    • Bandage contact lens: To retard corneal melting

  2. Pharmacotherapy

    • Topical corticosteroids: betamethasone 0.025-0.1% cream [nov]

    • Topical aryl hydrocarbon receptor (AhR) agonists

    • Ophthalmic corticosteroids

    • Intramuscular corticosteroids

    • Intralesional corticosteroids: resistant plaques and psoriatic nails

    • Coal tar 0.5-33%

    • Keratolytic agents (anthralin, urea): facilitate direct steroid contact with the skin

    • Vitamin D analogs (calcitriol ointment)

    • Topical retinoids

    • Antimetabolites (methotrexate)

    • Immunomodulators (tacrolimus topical 0.1%, cyclosporine, alefacept, ustekinumab)

    • Tumor necrosis factor (TNF) inhibitors (infliximab, etanercept, adalimumab)

    • Phosphodiesterase-4 inhibitors (apremilast, roflumilast topical)

    • Interleukin inhibitors

    • Artificial tears

Differential diagnoses

Conjunctivitis, Contact dermatitis, Cutaneous T-cell lymphoma, Eczema, Gout, Keratitis, Lichen planus, Lichen simplex chronicus, Mycosis fungoides, Onychomycosis, Pityriasis alba, Pityriasis rosea, Pseudogout, Psoriatic arthritis, Reactive arthritis, Rheumatoid arthritis, Seborrheic dermatitis, Squamous cell carcinoma, Syphilis, Tinea corporis, Tinea unguium


References

[1] Nair PA, Badri T. Psoriasis. [Updated 2023 Apr 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448194/

[2] https://emedicine.medscape.com/article/1943419

[3] Zhang Y, Dong S, Ma Y, Mou Y. Burden of psoriasis in young adults worldwide from the global burden of disease study 2019. Front Endocrinol (Lausanne). 2024 Feb 13;15:1308822.

[4] Dairov A, Issabekova A, Sekenova A, Shakhatbayev M, Ogay V. Prevalence, Incidence, Gender and Age Distribution, and Economic Burden of Psoriasis Worldwide and in Kazakhstan. J CLIN MED KAZ. 2024;21(2):18-30.

[5] Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, Guo C, Dellavalle R, Grada A, Wong P, La Vecchia C, Tam LS, Cooper KD, Naghavi M. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study. Front Med (Lausanne). 2021 Dec 16;8:743180.

[6] Deike M, Wang J, Brinks R, Meller S, Ocker L, Bechara FG, Distler JHW, Baraliakos X, Kiefer D, Sewerin P. Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Arch Dermatol Res. 2024 Jan 4;316(2):65.

[7] Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009 Mar;60(3):394-401.

[8] Parisi R, Symmons DP, Griffiths CE, Ashcroft DM; Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013 Feb;133(2):377-85.

[9] Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010 Jun;62(6):979-87.

[10] Burshtein J, Strunk A, Garg A. Incidence of psoriasis among adults in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2021 Apr;84(4):1023-1029.

[11] Egeberg A, Skov L, Gislason GH, Thyssen JP, Mallbris L. Incidence and Prevalence of Psoriasis in Denmark. Acta Derm Venereol. 2017 Jul 6;97(7):808-812.

[12] Mehrmal S, Uppal P, Nedley N, Giesey RL, Delost GR. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017. J Am Acad Dermatol. 2021 Jan;84(1):46-52.

[13] [Clinical Dermatology 4.th Edition by Weller, Hunter, Savin and Dahl]

[14] Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM; Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021 Feb;184(2):243-258.

Scroll to top